Hospital Microbiology Testing Market Size, Share & Trends Analysis Report By Application, Regional Outlook, Competitive Strategies, And Segment Forecasts, 2019 To 2025

The global hospital microbiology testing market is expected to witness lucrative growth over the forecast period owing to increase in awareness levels of people related to the onset of respiratory infections along with other chronic problems such as inflammatory disorders. Efficacy and availability of anti-viral treatments for diseases such as periodontitis, gingivitis, Chronic Pulmonary Obstructive Disease (COPD), and rise in sex-related awareness amongst the population in developing countries are the major drivers for the growth of the market. An increase in economic conditions along with various reimbursement policies, development of new hospital microbiology testing industry due to technological advancements, and increased investment in the companies are some other factors fueling the expansion of the hospital microbiology testing market. Various immunoassay techniques are implemented for rapid diagnosis of infection with accuracy that further leads to potential diagnostic platforms and technologies such as biochemical tests, microbial culture, and molecular diagnostics. Diseases such as HIV, Human Papilloma Virus (HPV), and Hepatitis B and C are forms of STDs that are severe and fatal, therefore increasing the demand for the hospital microbiology testing market. Increasing healthcare expenditure and the presence of better medical infrastructures such as hospitals and clinical labs are some other drivers of the augmentation in the market.

The hospital microbiology testing industry is segmented on the basis of procedure, products, and applications. Microbial culture, microscopy, biochemical tests, and molecular diagnostics are the procedure segments of the hospital microbiology testing market. On the basis of products, the segments are consumables and instruments. Consumables are further segmented into reagents and kits. Kits occupy the major market share amongst consumables owing to its rise in utility by healthcare and diagnostic centers. Instruments are sub-segmented into microbiology analyzers, automated microbiology instruments, and microbiology analyzers. It is estimated that automated microbiology instruments will experience rapid growth over the forecast period. Microbiology analyzers are segmented into microscopes, molecular diagnostic instruments, and mass spectrometers. Mass spectrometers are expected to experience a speedy development due to a rise in acceptance of the device as well as increasing efficiency. On the basis of applications, the market is segmented into respiratory diseases, periodontal diseases, sexually transmitted infections, and urinary tract infections. The major market share is covered by respiratory diseases owing to the rise in inflammatory diseases as a result of an increase in pollution in the surroundings along with certain chronic diseases such as asthma.

Based on geography, the hospital microbiology testing market is segmented into North America, Europe, Asia Pacific, Latin America, and MEA. In 2014, North-America held the largest market share in terms of revenue followed by Europe. Rising prevalence of various diseases among the population, sophisticated healthcare infrastructure, and growing need for advanced diagnostic testing are the key reasons behind North-America being the market leader. Developing economies of Asia Pacific such as India, China, and Brazil are expected to experience a favorable expansion over the forecast period. This is attributed to the tax benefits, favorable reimbursement scenario, and increasing medical tourism in these nations. Moreover, the prevalence and severity of diseases in emerging nations such as India, China, Indonesia, and Malaysia propels the growth in the region.

The Centers for Disease Control and Prevention (CDC) estimate that as many as 2 million hospital-acquired infections occur in the U.S. hospital each year, which are associated with more than 90,000 deaths. The Public Health England (PHE) scientists investigated an incident in late 2011 and early 2012, where infections associated with Pseudomonas aeruginosa caused the deaths of four neonates in Northern Ireland. Data from the Bureau of Labor Statistics estimated a 17% annual growth rate in clinical laboratory jobs and that 53,000 new jobs were created in this sector from 1998 through 2008. Some key players of the hospital microbiology testing market are Quidel Corporation, Dickinson and Company, F. Hoffmann-La Roche Ltd., Thermo-Fischer Scientific, Inc., Gen-Probe, Inc., Bio-Rad Laboratories, Inc., Abbott Laboratories, Inc., Siemens Healthcare Diagnostics, Inc., and Sysmex Corporation.